@article{235cffc623b244f78e8600b271aec57e,
title = "Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine",
keywords = "3122 Cancers, 317 Pharmacy, cancer vaccines, oncolytic viruses, PeptiCRAd, personalized medicine, tumor antigens, IMMUNITY, SENSITIVITY, ADENOVIRUS, ONCOLOGY, IMMUNOTHERAPY, NEOANTIGENS, CTLA-4, BLOCKADE, VIRUSES",
author = "Sara Feola and Salvatore Russo and Beatriz Martins and Alessandra Lopes and Ga{\"e}lle Vandermeulen and Vinciane Fluhler and {De Giorgi}, Camilla and Manlio Fusciello and Sari Pesonen and Erkko Yl{\"o}sm{\"a}ki and Gabriella Antignani and Jacopo Chiaro and Firas Hamdan and Michaela Feodoroff and Mikaela Gr{\"o}nholm and Vincenzo Cerullo",
note = "Publisher Copyright: Copyright {\textcopyright} 2022 Feola, Russo, Martins, Lopes, Vandermeulen, Fluhler, De Giorgi, Fusciello, Pesonen, Yl{\"o}sm{\"a}ki, Antignani, Chiaro, Hamdan, Feodoroff, Gr{\"o}nholm and Cerullo.",
year = "2022",
month = apr,
day = "14",
doi = "10.3389/fimmu.2022.826164",
language = "English",
volume = "13",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media SA",
}